Hyperbaric oxygen (HBOT) in chronic traumatic brain injury: oxygen, pressure, and gene therapy

Dr. Paul Harch, Clinical Professor of Medicine at Louisiana State University School of Medicine in New Orleans, concludes that hyperbaric oxygen therapy (HBOT) is a disease-modifying therapy for mild traumatic brain injury (TBI) and post-concussion syndrome (PCS).

Hyperbaric Oxygen Therapy (HBOT) is one of the safe, alternative therapies the BART Foundation believes may help brain injury survivors. Perhaps if HBOT becomes more widely accepted as a treatment option, TBI/ABI/PCS survivors will be able to gain better access to this life-changing treatment.

Dr. Harch’s study, published in the journal, Medical Gas Research, concludes that HBOT treatments delivered to civilian and military subjects with persistent PCS and mild TBI resulted in significant improvements in postconcussion symptoms, cognitive variables (memory, cognition/speed of information processing), and behavioral/ emotional problems (anxiety, depression, PTSD symptoms, sleep, and quality of life) compared to a randomly assigned control group. These improvements were duplicated in the control group after crossing over to HBOT. In both groups, most of the improvements were sustained and, in some areas, even improved, nearly three months after the last HBOT treatment, suggesting HBOT as a disease-modifying therapy for TBI and PPCS.

To read the full research article, visit the Medical Gas Research website.